Cargando…
Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus
PURPOSE: Excessive brain iron depositions were found in both patients with Parkinson’s disease (PD) and those with type 2 diabetes mellitus (T2DM). The present study aimed to explore iron deposition and heterogeneity in the extrapyramidal system in PD patients with T2DM using quantitative susceptibi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513156/ https://www.ncbi.nlm.nih.gov/pubmed/36177478 http://dx.doi.org/10.3389/fnagi.2022.975390 |
_version_ | 1784797994238869504 |
---|---|
author | Li, Wanyao Gao, Bingbing Du, Wei Jiang, Yuhan Yang, Jing Hu, Rui Liu, Yangyingqiu Liu, Na Zhang, Yukun Song, Qingwei Miao, Yanwei |
author_facet | Li, Wanyao Gao, Bingbing Du, Wei Jiang, Yuhan Yang, Jing Hu, Rui Liu, Yangyingqiu Liu, Na Zhang, Yukun Song, Qingwei Miao, Yanwei |
author_sort | Li, Wanyao |
collection | PubMed |
description | PURPOSE: Excessive brain iron depositions were found in both patients with Parkinson’s disease (PD) and those with type 2 diabetes mellitus (T2DM). The present study aimed to explore iron deposition and heterogeneity in the extrapyramidal system in PD patients with T2DM using quantitative susceptibility mapping (QSM) and further to reveal the effect of T2DM on the changes in brain iron in patients with PD. MATERIALS AND METHODS: A total of 38 PD patients with T2DM (PDDM), 30 PD patients without T2DM (PDND), and 20 asymptomatic control subjects (CSs) were recruited for this study. All subjects underwent multiple MRI sequences involving enhanced gradient echo T2 star weighted angiography (ESWAN). The magnetic sensitivity values (MSV) and volume of the whole nuclei (MSV(W), V(W)) and high iron region (MSV(RII), V(RII)) were measured on the bilateral caudate nucleus (CN), the putamen (PUT), the globus pallidus (GP), the substantia nigra (SN), the red nucleus (RN) and the dentate nucleus (DN). Clinical and laboratory data were recorded, especially for the Hoehn and Yahr (H-Y) stage, the Montreal Cognitive Assessment (MoCA), the Mini-Mental State Examination (MMSE), the Hamilton Depression Rating Scale (HAMD), and the Hamilton Anxiety Rating Scale (HAMA). All QSM data were compared between PDDM and PDND groups and correlated with clinical and laboratory data. RESULTS: Compared to the PDND group, the V(RII/)V(W) of the left CN was significantly increased in the PDDM group. Significantly higher MSV(W) and MSV(RII) were also found in the PDDM group, including bilateral SN of MSV(W), right PUT, and bilateral CN, GP, and SN of MSV(RII). The H-Y stage of the PDDM group was significantly higher than that of the PDND group. The MSV(RII) of bilateral RN of the PDDM group was positively correlated with the HAMA scores. HDL, DBP, and SBP levels were associated with MSV(RII) of right CN in the PDDM group. CONCLUSION: T2DM could aggravate the disease severity and anxiety in patients with PD. The iron distribution of deep gray matter nuclei in PD patients with T2DM was significantly heterogeneous, which was related to blood pressure and blood lipids. |
format | Online Article Text |
id | pubmed-9513156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95131562022-09-28 Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus Li, Wanyao Gao, Bingbing Du, Wei Jiang, Yuhan Yang, Jing Hu, Rui Liu, Yangyingqiu Liu, Na Zhang, Yukun Song, Qingwei Miao, Yanwei Front Aging Neurosci Neuroscience PURPOSE: Excessive brain iron depositions were found in both patients with Parkinson’s disease (PD) and those with type 2 diabetes mellitus (T2DM). The present study aimed to explore iron deposition and heterogeneity in the extrapyramidal system in PD patients with T2DM using quantitative susceptibility mapping (QSM) and further to reveal the effect of T2DM on the changes in brain iron in patients with PD. MATERIALS AND METHODS: A total of 38 PD patients with T2DM (PDDM), 30 PD patients without T2DM (PDND), and 20 asymptomatic control subjects (CSs) were recruited for this study. All subjects underwent multiple MRI sequences involving enhanced gradient echo T2 star weighted angiography (ESWAN). The magnetic sensitivity values (MSV) and volume of the whole nuclei (MSV(W), V(W)) and high iron region (MSV(RII), V(RII)) were measured on the bilateral caudate nucleus (CN), the putamen (PUT), the globus pallidus (GP), the substantia nigra (SN), the red nucleus (RN) and the dentate nucleus (DN). Clinical and laboratory data were recorded, especially for the Hoehn and Yahr (H-Y) stage, the Montreal Cognitive Assessment (MoCA), the Mini-Mental State Examination (MMSE), the Hamilton Depression Rating Scale (HAMD), and the Hamilton Anxiety Rating Scale (HAMA). All QSM data were compared between PDDM and PDND groups and correlated with clinical and laboratory data. RESULTS: Compared to the PDND group, the V(RII/)V(W) of the left CN was significantly increased in the PDDM group. Significantly higher MSV(W) and MSV(RII) were also found in the PDDM group, including bilateral SN of MSV(W), right PUT, and bilateral CN, GP, and SN of MSV(RII). The H-Y stage of the PDDM group was significantly higher than that of the PDND group. The MSV(RII) of bilateral RN of the PDDM group was positively correlated with the HAMA scores. HDL, DBP, and SBP levels were associated with MSV(RII) of right CN in the PDDM group. CONCLUSION: T2DM could aggravate the disease severity and anxiety in patients with PD. The iron distribution of deep gray matter nuclei in PD patients with T2DM was significantly heterogeneous, which was related to blood pressure and blood lipids. Frontiers Media S.A. 2022-09-13 /pmc/articles/PMC9513156/ /pubmed/36177478 http://dx.doi.org/10.3389/fnagi.2022.975390 Text en Copyright © 2022 Li, Gao, Du, Jiang, Yang, Hu, Liu, Liu, Zhang, Song and Miao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Li, Wanyao Gao, Bingbing Du, Wei Jiang, Yuhan Yang, Jing Hu, Rui Liu, Yangyingqiu Liu, Na Zhang, Yukun Song, Qingwei Miao, Yanwei Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus |
title | Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus |
title_full | Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus |
title_fullStr | Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus |
title_full_unstemmed | Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus |
title_short | Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson’s disease patients with type 2 diabetes mellitus |
title_sort | iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in parkinson’s disease patients with type 2 diabetes mellitus |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513156/ https://www.ncbi.nlm.nih.gov/pubmed/36177478 http://dx.doi.org/10.3389/fnagi.2022.975390 |
work_keys_str_mv | AT liwanyao irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT gaobingbing irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT duwei irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT jiangyuhan irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT yangjing irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT hurui irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT liuyangyingqiu irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT liuna irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT zhangyukun irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT songqingwei irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus AT miaoyanwei irondepositionheterogeneityinextrapyramidalsystemassessedbyquantitativesusceptibilitymappinginparkinsonsdiseasepatientswithtype2diabetesmellitus |